News
-
Coronavirus: Federal Council simplifies access to Covid certificate for recovered persons
-
Coronavirus: AstraZeneca withdraws authorisation application for COVID-19 vaccine in Switzerland
-
Review of medicines 2021: FOPH reduces prices
-
Federal Administrative Court, Decision C-1197/2018 from 12 October 2021
-
European Medicines Agency: Generating high-quality evidence from registry-based studies
-
Federal Administrative Court, Decision C-1050/2020 of 5 October 2021
-
CureVac withdraws authorisation application for COVID-19 vaccine
-
Federal Administrative Court, Decision C-5675/2018 from 10 August 2021
-
Federal Supreme Court, Decision 9C_612/2020 from 22 September 2021
-
Federal Council and Parliament recommend approving the Covid-19 Act
-
Federal Administrative Court, C–4236/2020 of 22 December 2020
-
Federal Administrative Court, Decision C-613/2018 of 7 September 2021
-
Federal Administrative Court, Decision C-6116/2018 of 22 September 2021
-
Federal Administrative Court, Decision C-6117/2018 of 22 September 2021
-
European Medicines Agency: First-in-class medicine to treat aggressive form of breast cancer
-
Coronavirus: Federal Council plans new vaccination drive
-
Update on reports of suspected adverse reactions to COVID-19 vaccines in Switzerland
-
Coronavirus: Confederation signs agreement with Janssen
-
Federal Administrative Court, Decision C-6113/2018 of 29 September 2021
-
Federal Administrative Court, Decision C-1306/2019, C-2651/2019 of 21 September 2021
-
Federal Administrative Court, Decision C-4368/2019 of 7 September 2021